- Home
- MAXN vs GNTA Comparison
MAXN vs GNTA Comparison
Compare MAXN & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAXN | GNTA |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | Singapore | Italy |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2M | 39.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MAXN | GNTA |
|---|---|---|
| Price | $3.00 | $1.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 75.6K | ★ 122.5K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $176,414,000.00 | N/A |
| Revenue This Year | $100.37 | N/A |
| Revenue Next Year | $24.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.49 | $1.35 |
| 52 Week High | $9.05 | $10.00 |
Technical Indicators
Market Signals| Indicator | MAXN | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 43.50 | 40.49 |
| Support Level | $2.81 | $1.80 |
| Resistance Level | $3.14 | $2.20 |
| Average True Range (ATR) | 0.22 | 0.24 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 49.53 | 59.77 |
Price Performance
Historical ComparisonAbout MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.